Literature DB >> 12099684

p53-independent apoptosis is induced by the p19ARF tumor suppressor.

Keitaro Tsuji1, Kiyohisa Mizumoto, Haruka Sudo, Keisuke Kouyama, Etsuro Ogata, Masaaki Matsuoka.   

Abstract

p19(ARF) is a potent tumor suppressor. By inactivating Mdm2, p19(ARF) upregulates p53 activities to induce cell cycle arrest and sensitize cells to apoptosis in the presence of collateral signals. It has also been demonstrated that cell cycle arrest is induced by overexpressed p19(ARF) in p53-deficient mouse embryonic fibroblasts, only in the absence of the Mdm2 gene. Here, we show that apoptosis can be induced without additional apoptosis signals by expression of p19(ARF) using an adenovirus-mediated expression system in p53-intact cell lines as well as p53-deficient cell lines. Also, in primary mouse embryonic fibroblasts (MEFs) lacking p53/ARF, p53-independent apoptosis is induced irrespective of Mdm2 status by expression of p19(ARF). In agreement, p19(ARF)-mediated apoptosis in U2OS cells, but not in Saos2 cells, was attenuated by coexpression of Mdm2. We thus conclude that there is a p53-independent pathway for p19(ARF)-induced apoptosis that is insensitive to inhibition by Mdm2. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12099684     DOI: 10.1016/s0006-291x(02)00723-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins.

Authors:  Annika Müer; Tim Overkamp; Bernd Gillissen; Antje Richter; Thomas Pretzsch; Ana Milojkovic; Bernd Dörken; Peter T Daniel; Philipp Hemmati
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

2.  Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms.

Authors:  Danielle B Ulanet; Douglas Hanahan
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

3.  Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.

Authors:  Xingwu Wang; Meng Zha; Xiaocheng Zhao; Peng Jiang; Wenjing Du; Andrew Y H Tam; Yide Mei; Mian Wu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

4.  Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.

Authors:  E Sugihara; T Shimizu; K Kojima; N Onishi; K Kai; J Ishizawa; K Nagata; N Hashimoto; H Honda; M Kanno; M Miwa; S Okada; M Andreeff; H Saya
Journal:  Oncogene       Date:  2011-10-10       Impact factor: 9.867

5.  MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.

Authors:  Yang Peng; Wen Dong; Tian-Xin Lin; Guang-Zheng Zhong; Bei Liao; Bo Wang; Peng Gu; Li Huang; Yun Xie; Fu-Ding Lu; Xu Chen; Wei-Bin Xie; Wang He; Shao-Xu Wu; Jian Huang
Journal:  Oncotarget       Date:  2015-06-30

6.  A genotoxic stress-responsive miRNA, miR-574-3p, delays cell growth by suppressing the enhancer of rudimentary homolog gene in vitro.

Authors:  Ken-ichi Ishikawa; Atsuko Ishikawa; Yoshimi Shoji; Takashi Imai
Journal:  Int J Mol Sci       Date:  2014-02-20       Impact factor: 5.923

Review 7.  Dynamics of ARF regulation that control senescence and cancer.

Authors:  Aram Ko; Su Yeon Han; Jaewhan Song
Journal:  BMB Rep       Date:  2016-11       Impact factor: 4.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.